Single-centre Study of Everolimus as GvHD Prophylaxis After Post-Transplantation Cyclophosphamide After Allogeneic SCT
Clinical trial NCT02812940 · COMPLETED
Trial details
- NCT number
- NCT02812940
- Sponsor
- University of Cologne
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2019-07-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.